Jones Financial Companies
SNDX icon

Jones Financial Companies’s Syndax Pharmaceuticals SNDX Stock Holding History

Jones Financial Companies’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49K Buy
2,300
+1,711
+290% +$35.6K ﹤0.01% 3143
2026
Q1 		$13.8K Buy
589
+314
+114% +$6.82K ﹤0.01% 3448
2025
Q4 		$5.78K Hold
275
– – ﹤0.01% 3441
2025
Q3 		$4.31K Hold
275
– – ﹤0.01% 3412
2025
Q2 		$2.49K Buy
+275
New +$3.03K ﹤0.01% 3394

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Jones Financial Companies's SNDX Position: Q2 2026 in Review

Jones Financial Companies increased its Syndax Pharmaceuticals (SNDX) stake by 290% in Q2 2026, buying an estimated $35.6K and bringing the position to 2,300 shares worth $49K. The position accounts for ﹤0.01% of the portfolio, ranked #3143.

Jones Financial Companies first reported a position in SNDX in Q2 2025 and has held it in 5 quarters since. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Jones Financial Companies held 2,300 shares of Syndax Pharmaceuticals worth $49K as of Q2 2026.
  • Jones Financial Companies bought 1,711 Syndax Pharmaceuticals shares in Q2 2026, an estimated $35.6K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3143 holding.
  • Jones Financial Companies first reported a position in Syndax Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.